{"id":5682,"date":"2025-05-19T20:15:05","date_gmt":"2025-05-19T20:15:05","guid":{"rendered":"https:\/\/sandeepairtravel.com\/index.php\/2025\/05\/19\/envisioning-the-future-of-personalized-medicine-2\/"},"modified":"2025-05-19T20:15:05","modified_gmt":"2025-05-19T20:15:05","slug":"envisioning-the-future-of-personalized-medicine-2","status":"publish","type":"post","link":"https:\/\/sandeepairtravel.com\/index.php\/2025\/05\/19\/envisioning-the-future-of-personalized-medicine-2\/","title":{"rendered":"Envisioning the Future of Personalized Medicine: Role and Realities of Digital Twins"},"content":{"rendered":"

\"personalized<\/p>\n

In clinical biochemistry, adhering https:\/\/obatmurah.com\/are-longevity-drugs-the-key-to-extending-human-life.html<\/a> to existing rules when developing new technologies is essential to ensure safety, efficacy, and ethical standards (166). Regulatory bodies like the FDA, EMA, and CLSI are vital for assessing and approving different technologies and prioritizing safety, efficacy, and quality. Procedures can vary because of the unique features and challenges of technologies such as in vitro diagnostic equipment, biosensors, and AI-based software (167, 168). The regulation of new devices, such as ML and AI, involves algorithm transparency, data privacy, and adapting evolving models. Partnerships between organizations, such as the Global Harmonization Task Force (GHTF) and the International Medical Device Regulators Forum (IMDRF), are necessary to address these challenges on a global scale (169).<\/p>\n<\/p>\n